hydroxychloroquine has been researched along with Pericarditis in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Pericarditis: Inflammation of the PERICARDIUM from various origins, such as infection, neoplasm, autoimmune process, injuries, or drug-induced. Pericarditis usually leads to PERICARDIAL EFFUSION, or CONSTRICTIVE PERICARDITIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glucocorticoid (GC)-dependent, colchicine-resistant idiopathic recurrent pericarditis (IRP) remains a clinical challenge." | 7.96 | Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study. ( Antonatou, K; Antonopoulos, AS; Hadziyannis, E; Lazaros, G; Lazarou, E; Leontsinis, I; Ritis, K; Simantiris, S; Skendros, P; Tousoulis, D; Vassilopoulos, D; Vlachopoulos, C, 2020) |
| "Glucocorticoid (GC)-dependent, colchicine-resistant idiopathic recurrent pericarditis (IRP) remains a clinical challenge." | 3.96 | Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study. ( Antonatou, K; Antonopoulos, AS; Hadziyannis, E; Lazaros, G; Lazarou, E; Leontsinis, I; Ritis, K; Simantiris, S; Skendros, P; Tousoulis, D; Vassilopoulos, D; Vlachopoulos, C, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lazaros, G | 1 |
| Antonopoulos, AS | 1 |
| Antonatou, K | 1 |
| Skendros, P | 1 |
| Ritis, K | 1 |
| Hadziyannis, E | 1 |
| Lazarou, E | 1 |
| Leontsinis, I | 1 |
| Simantiris, S | 1 |
| Vlachopoulos, C | 1 |
| Tousoulis, D | 1 |
| Vassilopoulos, D | 1 |
| Jacquet-Lagrèze, M | 1 |
| Riad, Z | 1 |
| Hugon-Vallet, E | 1 |
| Ferraris, A | 1 |
| Fellahi, JL | 1 |
| Fanouriakis, A | 1 |
| Tziolos, N | 1 |
| Bertsias, G | 1 |
| Boumpas, DT | 1 |
| Donado, CD | 1 |
| Díez, EM | 1 |
| Sunkureddi, PR | 1 |
| Gonzalez, EB | 1 |
| Washington, R | 1 |
| Salazar, A | 1 |
| Douglass, P | 1 |
| Kwon, CM | 1 |
| Jung, YW | 1 |
| Yun, DY | 1 |
| Kim, HD | 1 |
| Cho, HS | 1 |
| Hong, YH | 1 |
| Choi, JH | 1 |
| Lee, CK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Optimization of Glucocorticoid Taper Strategies for Maintenance Therapy of Systemic Lupus Erythematosus Associated Immune Thrombocytopenia (SLE-ITP)[NCT05506033] | 120 participants (Anticipated) | Interventional | 2022-08-15 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for hydroxychloroquine and Pericarditis
| Article | Year |
|---|---|
Left ventricular dysfunction in COVID-19: A diagnostic issue.
Topics: Azithromycin; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Cytokine Release Syndro | 2020 |
Update οn the diagnosis and management of systemic lupus erythematosus.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Autoantibodies; Azathioprine; Calc | 2021 |
4 other studies available for hydroxychloroquine and Pericarditis
| Article | Year |
|---|---|
Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study.
Topics: Colchicine; Glucocorticoids; Humans; Hydroxychloroquine; Pericarditis; Prospective Studies; Recurren | 2020 |
Successful desensitization for hydroxychloroquine anaphylaxis.
Topics: Anaphylaxis; Antirheumatic Agents; Desensitization, Immunologic; Humans; Hydroxychloroquine; Lupus E | 2010 |
A 39-year-old man with sudden onset of chest pain.
Topics: Acute Disease; Adult; Antirheumatic Agents; Chest Pain; Diagnosis, Differential; Drug Therapy, Combi | 2005 |
A case of acute pericarditis with hemophagocytic syndrome, cytomegalovirus infection and systemic lupus erythematosus.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Cytomegalovirus Infections; Gastrointestinal Hemorrh | 2008 |